Diagnosis, treatment, and outcome of patients with oesophagogastric cancer during the COVID-19 pandemic: national study
British Journal of Surgery · 2023
DOI: 10.1093/bjs/znad003 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Surgery, 2023. Verfasst von Mark A Baxter und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Molecular and Clinical Medicine, Ninewells Hospital and Medical School, University of Dundee, Dundee, UK. Hauptthemen laut MEDLINE: COVID-19, Stomach Neoplasms, Esophageal Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
The national response to COVID-19 has had a significant impact on cancer services. This study investigated the effect of national lockdown on diagnosis, management, and outcomes of patients with oesophagogastric cancers in Scotland.
Methods
This retrospective cohort study included consecutive new patients presenting to regional oesophagogastric cancer multidisciplinary teams in National Health Service Scotland between October 2019 and September 2020. The study interval was divided into before and after lockdown, based on the first UK national lockdown. Electronic health records were reviewed and results compared.
Results
Some 958 patients with biopsy-proven oesophagogastric cancer in 3 cancer networks were included: 506 (52.8 per cent) before and 452 (47.2 per cent) after lockdown. Median age was 72 (range 25–95) years and 630 patients (65.7 per cent) were men. There were 693 oesophageal (72.3 per cent) and 265 gastric (27.7 per cent) cancers. Median time to gastroscopy was 15 (range 0–337) days before versus 19 (0–261) days after lockdown (P < 0.001). Patients were more likely to present as an emergency after lockdown (8.5 per cent before versus 12.4 per cent after lockdown; P = 0.005), had poorer Eastern Cooperative Oncology group performance status, were more symptomatic, and presented with a higher stage of disease (stage IV: 49.8 per cent before versus 58.8 per cent after lockdown; P = 0.04). There was a shift to treatment with non-curative intent (64.6 per cent before versus 77.4 per cent after lockdown; P < 0.001). Median overall survival was 9.9 (95 per cent c.i. 8.7 to 11.4) months before and 6.9 (5.9 to 8.3) months after lockdown (HR 1.26, 95 per cent c.i. 1.09 to 1.46; P = 0.002).
Conclusion
This national study has highlighted the adverse impact of COVID-19 on oesophagogastric cancer outcomes in Scotland. Patients presented with more advanced disease and a shift towards treatment with non-curative intent was observed, with a subsequent negative impact on overall survival.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Molecular and Clinical Medicine, Ninewells Hospital and Medical School, University of Dundee, Dundee, UK.
- Tayside Cancer Centre, Ninewells Hospital and Medical School, NHS Tayside, Dundee, UK.
- Department of Upper Gastrointestinal Surgery, University Hospital Hairmyres, East Kilbride, UK.
- School of Medicine, Dentistry and Nursing, University of Glasgow, Glasgow, UK.
- Department of Upper Gastrointestinal Surgery, Glasgow Royal Infirmary, Glasgow, UK.
- Department of Oncology, Edinburgh Cancer Centre, Edinburgh, UK.
ORCID-Profile: Mark A Baxter, Khurram S Khan
Zitieren
APA
Baxter, M. A., Khan, K. S., Gall, L. S., Samuelson, C., McCollum, C., Chuntamongkol, R., Narramneni, L. R., Al-Zuabi, M., Bryce, G., Shareef, H. E. J., Forshaw, M., & Petty, R. D. (2023). Diagnosis, treatment, and outcome of patients with oesophagogastric cancer during the COVID-19 pandemic: national study. British Journal of Surgery. https://doi.org/10.1093/bjs/znad003
Vancouver
Baxter MA, Khan KS, Gall LS, Samuelson C, McCollum C, Chuntamongkol R, et al. Diagnosis, treatment, and outcome of patients with oesophagogastric cancer during the COVID-19 pandemic: national study. British Journal of Surgery. 2023. doi:10.1093/bjs/znad003
BibTeX
@article{Baxter2023,
author = {Baxter, Mark A and Khan, Khurram S and Gall, Lewis S and Samuelson, Catherine and McCollum, Catherine and Chuntamongkol, Rongkagorn and Narramneni, Lakshmi R and Al-Zuabi, Manaf and Bryce, Gavin and Shareef, Hala E J and Forshaw, Matthew and Petty, Russell D},
title = {Diagnosis, treatment, and outcome of patients with oesophagogastric cancer during the COVID-19 pandemic: national study},
journal = {British Journal of Surgery},
year = {2023},
doi = {10.1093/bjs/znad003}
}
EUVIMED